María Winnock

2.0k total citations
57 papers, 1.4k citations indexed

About

María Winnock is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, María Winnock has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 37 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in María Winnock's work include Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (17 papers). María Winnock is often cited by papers focused on Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (17 papers). María Winnock collaborates with scholars based in France, Belize and Japan. María Winnock's co-authors include L. Stinus, Ann E. Kelley, Paulette Bioulac‐Sage, Charles Balabaud, Brigitte Le Bail, D. Neau, Victor de Lédinghen, Jean Saric, Laurent Castéra and Thierry Lamireau and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

María Winnock

57 papers receiving 1.4k citations

Peers

María Winnock
P Madoz Spain
P. J. Grob Switzerland
Katie Smith United States
Tiffany Wong Hong Kong
P. Disdier France
G Torelli Italy
Neeti Agarwal United States
P Madoz Spain
María Winnock
Citations per year, relative to María Winnock María Winnock (= 1×) peers P Madoz

Countries citing papers authored by María Winnock

Since Specialization
Citations

This map shows the geographic impact of María Winnock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Winnock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Winnock more than expected).

Fields of papers citing papers by María Winnock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Winnock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Winnock. The network helps show where María Winnock may publish in the future.

Co-authorship network of co-authors of María Winnock

This figure shows the co-authorship network connecting the top 25 collaborators of María Winnock. A scholar is included among the top collaborators of María Winnock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Winnock. María Winnock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miailhes, Patrick, Camille Gilbert, Karine Lacombe, et al.. (2015). Triple therapy with boceprevir or telaprevir in a E uropean cohort of cirrhotic HIV / HCV genotype 1‐coinfected patients. Liver International. 35(9). 2090–2099. 5 indexed citations
2.
Carrieri, Patrizia, C. Lions, Philippe Sogni, et al.. (2013). Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study. Journal of Hepatology. 60(1). 46–53. 17 indexed citations
3.
Trimoulet, Pascale, María Winnock, Hervé Fleury, et al.. (2012). Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: Should the same test be applied to all samples?. Journal of Virological Methods. 181(1). 131–133. 2 indexed citations
4.
Solas, Caroline, Élodie Pambrun, María Winnock, et al.. (2012). Ribavirin and abacavir drug interaction in HIV–HCV coinfected patients. AIDS. 26(17). 2193–2199. 10 indexed citations
5.
Abravanel, Florence, Stéphanie Raymond, Élodie Pambrun, et al.. (2012). HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients. PLoS ONE. 7(11). e50289–e50289. 3 indexed citations
6.
Bourcier, Valérie, María Winnock, Élodie Pambrun, et al.. (2011). Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clinics and Research in Hepatology and Gastroenterology. 36(3). 214–221. 33 indexed citations
7.
Salmon, Dominique, Firouzé Bani‐Sadr, Anne Gervais, et al.. (2011). Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH. Journal of Hepatology. 56(4). 862–868. 36 indexed citations
9.
Winnock, María, Firouzé Bani‐Sadr, Élodie Pambrun, et al.. (2011). Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine. 29(47). 8656–8660. 17 indexed citations
10.
Neau, D., María Winnock, Laurent Castéra, et al.. (2007). Prevalence of and Factors Associated With Hepatic Steatosis in Patients Coinfected With Hepatitis C Virus and HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 168–173. 20 indexed citations
11.
Trimoulet, Pascale, Mathieu Boutonnet, María Winnock, et al.. (2007). Hepatitis B virus genotypes : a retrospective survey in Southwestern France, 1999-2004. Gastroentérologie Clinique et Biologique. 31(12). 1088–1094. 19 indexed citations
12.
Castéra, Laurent, Brigitte Le Bail, Patrick Coffié, et al.. (2007). Hepatic steatosis in HIV‐HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype. Alimentary Pharmacology & Therapeutics. 26(11-12). 1489–1498. 36 indexed citations
13.
Lamireau, Thierry, et al.. (2004). Epidemiology of liver disease in cystic fibrosis: a longitudinal study. Journal of Hepatology. 41(6). 920–925. 136 indexed citations
14.
Rullier, Anne, Pascale Trimoulet, D. Neau, et al.. (2004). Fibrosis is worse in HIV-HCV patients with low-level immunodepression referred for HCV treatment than in HCV-matched patients. Human Pathology. 35(9). 1088–1094. 15 indexed citations
15.
Lédinghen, Victor de, Pascale Trimoulet, María Winnock, et al.. (2002). Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone. Journal of Hepatology. 36(6). 819–826. 16 indexed citations
16.
Trimoulet, Pascale, D. Neau, Brigitte Le Bail, et al.. (2002). Intrahepatic HCV RNA loads in 37 HIV‐HCV co‐infected patients with controlled HIV infection. Journal of Medical Virology. 67(2). 143–151. 32 indexed citations
17.
Lédinghen, Victor de, David Laharie, R. Lecesne, et al.. (2002). Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. European Journal of Gastroenterology & Hepatology. 14(2). 159–165. 94 indexed citations
18.
Rullier, Anne, Pascale Trimoulet, María Winnock, et al.. (2001). Immunohistochemical Detection of HCV in Cirrhosis, Dysplastic Nodules, and Hepatocellular Carcinomas with Parallel-Tissue Quantitative RT-PCR. Modern Pathology. 14(5). 496–505. 17 indexed citations
19.
Neau, D., Pascale Trimoulet, María Winnock, et al.. (2001). Impact of protease inhibitors on intrahepatic hepatitis C virus viral load. AIDS. 15(13). 1736–1738. 21 indexed citations
20.
Blanc, Jean‐Frédéric, Victor de Lédinghen, Pierre–Henri Bernard, et al.. (2000). Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. Journal of Hepatology. 32(5). 805–811. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026